ROCHE WINS EU APPROVAL FOR CANCER DRUG AVASTIN

Roche Holding AG has won European Union approval for its colon cancer treatment Avastin, which helped drive growth at the Swiss drugmaker last year after sales got off to a flying start in the U.S. Roche said on Friday that the drug had been granted marketing approval by EU regulators, as expected, as a first-line treatment for colon cancer in combination with certain kinds of chemotherapy.

Reuters (http://www.reuters.com/newsArticle.jhtml?storyID=7329082)